Gupta, R., Othman, T., Chen, C., Sandhu, J., Ouyang, C., & Fakih, M. (2019). Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer. Oncologist.

Gupta, Rohan, Tamer Othman, Chen Chen, Jaideep Sandhu, Ching Ouyang, och Marwan Fakih. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.

Gupta, Rohan, et al. "Guardant360 Circulating Tumor DNA Assay Is Concordant With FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer." Oncologist 2019.